The company now expects $650 million to $700 million in revenue ... paired with milestone payments and royalties for 20 years ...

The company now expects $650 million to $700 million in revenue for the year, down from previous guidance of $700 million to ...

Enjovo, a forward-thinking U.S.-based candy startup, is set to shake up the global confectionery industry with its unique approach to candy dispensing. The company has developed a patented ...

CommScope , a global leader in network connectivity, announced today that it has partnered with the Cleveland Cavaliers to provide 5G connectivity at Rocket Mortgage FieldHouse. The advanced mobile ...

BofA lowered the firm’s price target on Novavax (NVAX) to $12 from $14 and keeps a Neutral rating on the shares. The company announced ...

Eric Joseph has given his Sell rating due to a combination of factors affecting Novavax’s current and future performance. One major concern is the company’s underwhelming market share for its COVID ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

"We were hopeful to get a larger market share this year," Novavax CEO John Jacobs said in an interview, adding the company ...

During the third quarter, Novavax entered into a material transfer agreement with a leading pharmaceutical company to ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.

Novavax shares dropped Tuesday morning after the company slashed its full-year outlook when it announced its third-quarter results.